Cited by 2,803Cancer-related Molecular PathwaysDNA Repair MechanismsMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., Vogelstein, B.·1998·Science

DOI 10.1126/science.282.5393.1497

Open this paper in CoChat — free account

Abstract

After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.

Integrity signals

Registry

Crossref · 10.1126/science.282.5393.1497

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Cell Cycle Control and Cancer
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citation
Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation

Show all 50 references

Research works printed but not linked: 13

Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
Powell S. N., et al., Cancer Res. 55, 1643 (1995);
Fan S., et al., Cancer Res. 55, 1649 (1995);
Russell K. J., et al., ibid. 55, 1639 (1995).
Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
Michieli P., et al., Cancer Res. 54, 3391 (1994);
Paules R. S., et al., Cancer Res 55, 1763 (1995);
Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);

Sorted by citations

Items 301–400 of 1,018

p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage Checkpoint
Ande, S., Hilton, M. B., & Kaldis, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0525 · Cited by 168
The role of DNA damage responses in p53 biology
Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 172
Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line.
Zhong, W., & Oberley, T. D. (2001) · PubMed · Cited by 164
Mutations in apoptosis genes: a pathogenetic factor for human disease
Müllauer, L., Gruber, P., Sebinger, D., Buch, J., Wohlfart, S., & Chott, A. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00057-6 · Cited by 166
The Haemophilus ducreyi Cytolethal Distending Toxin Induces Cell Cycle Arrest and Apoptosis via the DNA Damage Checkpoint Pathways
Cortes-Bratti, X., Karlsson, C., Lagergård, T., Thelestam, M., & Frisan, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008527200 · Cited by 162
Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse
Mahyar-Roemer, M., Katsen, A. D., Mestres, P., & Roemer, K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1516 · Cited by 162
The G2 DNA damage checkpoint targets both Wee1 and Cdc25
Raleigh, J., & O’Connell, M. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1727 · Cited by 162
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
Pro-proliferative FoxM1 is a target of p53-mediated repression
Barsotti, A. M., & Prives, C. L. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 163
DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 168
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents
Mahyar-Roemer, M., & Roemer, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204440 · Cited by 161
Involvement of Sphingosine Kinase 2 in p53-Independent Induction of p21 by the Chemotherapeutic Drug Doxorubicin
Sankala, H. M., Hait, N. C., Paugh, S. W., Shida, D., Lépine, S., Elmore, L. W., Dent, P., Milstien, S., & Spiegel, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2090 · Cited by 166
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
Zheng, L., Zhang, Y., Liu, Y., Zhou, M., Lu, Y., Li, Y., Zhang, C., Hong, M., Wang, S., & Li, X. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0592-z · Cited by 159
Splicing Regulator SC35 Is Essential for Genomic Stability and Cell Proliferation during Mammalian Organogenesis
Xiao, R., Sun, Y., Ding, J., Lin, S., Rose, D. W., Rosenfeld, M. G., Fu, X., & Li, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00288-07 · Cited by 164
Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation
Das, S., Raj, L., Zhao, B., Kimura, Y., Bernstein, A., Aaronson, S. A., & Lee, S. W. (2007) · Cell · doi:10.1016/j.cell.2007.06.013 · Cited by 160
Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells
Byrne, S. M., Ortiz, L., Mali, P., Aach, J., & Church, G. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1246 · Cited by 158
Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer
Li, X. L., Subramanian, M., Jones, M. F., Chaudhary, R., Singh, D. K., Zong, X., Gryder, B. E., Sindri, S., Mo, M., Schetter, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.041 · Cited by 163
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
Li, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 160
Human DNA repair genes
Ronen, A., & Glickman, B. W. (2001) · Environmental and Molecular Mutagenesis · doi:10.1002/em.1033 · Cited by 161
A specific PP2A regulatory subunit, B56γ, mediates DNA damage‐induced dephosphorylation of p53 at Thr55
Li, H., Cai, X., Shouse, G., Piluso, L. G., & Liu, X. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601519 · Cited by 163
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
Rahman, R., Latonen, L., & Wiman, K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1208232 · Cited by 159
Exploiting cancer cell cycling for selective protection of normal cells.
Blagosklonny, M. V., & Pardee, A. B. (2001) · PubMed · Cited by 157
The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
Jallepalli, P. V., Lengauer, C., Vogelstein, B., & Bunz, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213159200 · Cited by 154
Self-citation
Catalytic Function of the PR-Set7 Histone H4 Lysine 20 Monomethyltransferase Is Essential for Mitotic Entry and Genomic Stability
Houston, S. I., McManus, K. J., Adams, M. M., Sims, J. K., Carpenter, P. B., Hendzel, M. J., & Rice, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710579200 · Cited by 154
p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1
Vega, F. M. D. L., Sevilla, A., & Lazo, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10366-10380.2004 · Cited by 155
The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax
Samuel, T., Weber, H. O., Rauch, P., Verdoodt, B., Eppel, J.-T., McShea, A., Hermeking, H., & Funk, J. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106427200 · Cited by 154
Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway
Wu, S., Wang, H., Li, Y., Xie, Y., Huang, C., Zhao, H., Miyagishi, M., & Kasim, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4047 · Cited by 153
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin
Tsvetkov, P., Asher, G., Reiss, V., Shaul, Y., Sachs, L., & Lotem, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501828102 · Cited by 153
A pivotal role for p53: balancing aerobic respiration and glycolysis
Ma, W., Sung, H. J., Park, J., Matoba, S., & Hwang, P. M. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9083-0 · Cited by 153
Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells
Li, Y.-C., He, S.-M., He, Z.-X., Li, M., Yang, Y., Jian-xin, P., Zhang, X., Chow, K., Zhou, Q. S., Duan, W., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.001 · Cited by 152
Self-citation
Doxorubicin Induces Apoptosis in Germ Line Stem Cells in the Immature Rat Testis and Amifostine Cannot Protect against This Cytotoxicity
Hou, M., Chrysis, D., Nurmio, M., Parvinen, M., Eksborg, S., Söder, O., & Jahnukainen, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2004 · Cited by 152
Tumor suppressor p53: regulation and function
Somasundaram, K. (2000) · Frontiers in bioscience · doi:10.2741/somasund · Cited by 155
Uncoupling between Phenotypic Senescence and Cell Cycle Arrest in Aging p21-Deficient Fibroblasts
Dulić, V., Beney, G.-E., Frebourg, G., Drullinger, L. F., & Stein, G. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6741-6754.2000 · Cited by 149
Cross talk between stimulated NF-κB and the tumor suppressor p53
Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149
Transcriptional Blockade Induces p53-dependent Apoptosis Associated with Translocation of p53 to Mitochondria
Arima, Y., Nitta, M., Kuninaka, S., Zhang, D., Fujiwara, T., Taya, Y., Nakao, M., & Saya, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410691200 · Cited by 149
Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
MacFarlane, M., Inoue, S., Kohlhaas, S. L., Majid, A., Harper, N. W., Kennedy, D. B., Dyer, M. J. S., & Cohen, G. M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401649 · Cited by 156
p53 accumulates but is functionally impaired when DNA synthesis is blocked
Gottifredi, V., Shieh, S.-Y., Taya, Y., & Prives, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1036 · Cited by 147
Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction
Allen, J. G., Bourbeau, M. P., Wohlhieter, G. E., Bartberger, M. D., Michelsen, K., Hungate, R. W., Gadwood, R. C., Gaston, R. D., Evans, B., Mann, L. W., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900681h · Cited by 149
DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint
Huang, X., Tran, T. T., Zhang, L., Hatcher, R. J., & Zhang, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409130102 · Cited by 150
Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells
Watson, J. L., Hill, R., Yaffe, P. B., Greenshields, A. L., Walsh, M. J., Lee, P. W. K., Giacomantonio, C. A., & Hoskin, D. W. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.018 · Cited by 148
Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
Mitra, S., Anand, U., Jha, N. K., Shekhawat, M. S., Saha, S. C., Nongdam, P., Rengasamy, K. R. R., Proćków, J., & Dey, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.772418 · Cited by 151
Fools rush in
Piwnica-Worms, H. M. (1999) · Nature · doi:10.1038/44029 · Cited by 147
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels
Iyer, N. G., Chin, S., Özdağ, H., Daigo, Y., Hu, D., Cariati, M., Brindle, K. M., Aparicio, S. A. J. R., & Caldas, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401002101 · Cited by 147
miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit
Song, B., Wang, Y., Kudo, K., Gavin, E. J., Xi, Y., & Ju, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1422 · Cited by 148
Oncogene-like addiction to aneuploidy in human cancers
Girish, V., Lakhani, A. A., Thompson, S. L., Scaduto, C. M., Brown, L. M., Hagenson, R. A., Sausville, E. L., Mendelson, B. E., Kandikuppa, P. K., Lukow, D. A., et al. (2023) · Science · doi:10.1126/science.adg4521 · Cited by 148
P53: An ubiquitous target of anticancer drugs
Blagosklonny, M. V. (2001) · International Journal of Cancer · doi:10.1002/ijc.10158 · Cited by 146
Regulation of p21WAF1/CIP1 Stability by WISp39, a Hsp90 Binding TPR Protein
Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Fotedar, R., & Fotedar, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.049 · Cited by 145
CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo
Tse, A. N., Rendahl, K. G., Sheikh, T. N., Cheema, H., Aardalen, K., Embry, M. G., Ma, S., Moler, E. J., Ni, Z., de Menezes, D. E. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1424 · Cited by 145
Involvement of Crm1 in Hepatitis B Virus X Protein-Induced Aberrant Centriole Replication and Abnormal Mitotic Spindles
Forgues, M., Difilippantonio, M. J., Linke, S. P., Ried, T., Nagashima, K., Feden, J. P., Valerie, K. C., Fukasawa, K., & Wang, X. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5282-5292.2003 · Cited by 145
Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
Yang, W., Mathew, J., Velcich, A., Edelmann, W., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. H. (2001) · PubMed · Cited by 145
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 144
Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143
Down‐regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1‐dependent DNA‐damage checkpoint signals contributes to cell cycle arrest at G1/S transition
Arima, Y., Hirota, T., Bronner, C., Mousli, M., Fujiwara, T., Niwa, S., Ishikawa, H. T., & Saya, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00710.x · Cited by 151
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 143
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
Alarcon, R. M., Koumenis, C., Geyer, R. K., Maki, C. G., & Giaccia, A. J. (1999) · PubMed · Cited by 143
A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
Mullenders, J., Fabius, A. W. M., Madiredjo, M., Bernards, R., & Beijersbergen, R. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004798 · Cited by 146
Cyclin E-induced replicative stress drives p53-dependent whole-genome duplication
Zeng, J., Hills, S. A., Ozono, E., & Diffley, J. F. X. (2023) · Cell · doi:10.1016/j.cell.2022.12.036 · Cited by 144
Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
Yih, L., & Lee, T. (2000) · PubMed · Cited by 142
CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells
Li, W., Ge, Z., Liu, C., Liu, Z., Björkholm, M., Jia, J., & Xu, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4137 · Cited by 142
Role of reactive oxygen species and MAPKs in vanadate-induced G2/M phase arrest
Zhang, Z., Leonard, S. S., Huang, C., Vallyathan, V., Castranova, V., & Shi, X. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00145-x · Cited by 141
Hydrogen sulfide‐induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells
Baskar, R., Li, L., & Moore, P. K. (2006) · The FASEB Journal · doi:10.1096/fj.06-6255com · Cited by 141
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
Tai, I. T., Dai, M., Owen, D. A., & Chen, L. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23002 · Cited by 140
A cell‐based model system links chromothripsis with hyperploidy
Mardin, B. R., Drainas, A. P., Waszak, S. M., Weischenfeldt, J., Isokane, M., Stütz, A. M., Raeder, B., Efthymiopoulos, T., Buccitelli, C., Segura‐Wang, M., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156505 · Cited by 144
DNA damage induces two distinct modes of cell death in ovarian carcinomas
Vakifahmetoglu, H., Olsson, M., Tamm, C., Heidari, N., Orrenius, S., & Zhivotovsky, B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402286 · Cited by 140
Choline Phospholipid Metabolism in Cancer: Consequences for Molecular Pharmaceutical Interventions
Glunde, K., Ackerstaff, E., Mori, N., Jacobs, M. A., & Bhujwalla, Z. M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060067e · Cited by 140
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation
Xavier, C. P. R., Lima, C. F., Rohde, M., & Pereira‐Wilson, C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1641-9 · Cited by 141
Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase
Salomon, A. R., Voehringer, D. W., Herzenberg, L. A., & Khosla, C. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00057-0 · Cited by 140
MYC Is a Major Determinant of Mitotic Cell Fate
Topham, C. H., Tighe, A., Ly, P., Bennett, A., Sloss, O., Nelson, L., Ridgway, R. A., Huels, D. J., Littler, S., Schandl, C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.06.001 · Cited by 144
Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks Cancer Cell Invasion
Ferrari‐Amorotti, G., Fragliasso, V., Esteki, R., Prudente, Z., Soliera, A. R., Cattelani, S., Manzotti, G., Grisendi, G., Dominici, M., Pieraccioli, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1739 · Cited by 139
Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression
Herceg, Z., Hulla, W., Gell, D. A., Cuenin, C., LLeonart, M. E., Jackson, S. P., & Wang, Z. (2001) · Nature Genetics · doi:10.1038/ng725 · Cited by 148
Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB
Fujioka, S., Schmidt, C., Sclabas, G. M., Li, Z., Pelicano, H., Peng, B., Yao, A., Niu, J., Zhang, W., Evans, D. B., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313435200 · Cited by 139
E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis
Liu, J., Zhang, C., Wang, X. L., Ly, P., Белый, В. А., Xu-Monette, Z. Y., Young, K. H., Hu, W., & Feng, Z. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.121 · Cited by 139
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
Allison, S. J., Knight, J. R. P., Granchi, C., Rani, R., Minutolo, F., Milner, J., & Phillips, R. M. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.16 · Cited by 137
CENPA overexpression promotes genome instability in pRb-depleted human cells
Amato, A. M., Schillaci, T., Lentini, L., & Leonardo, A. D. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-119 · Cited by 145
Overexpression of MYC causes p53 -dependent G 2 arrest of normal fibroblasts
Felsher, D. W., Zetterberg, A., Zhu, J., Tlsty, T. D., & Bishop, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190327097 · Cited by 137
Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner
Potapova, O., Gorospe, M., Dougherty, R. H., Dean, N. M., Gaarde, W. A., & Holbrook, N. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1713-1722.2000 · Cited by 136
Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis
Qiu, W., Leibowitz, B. J., Zhang, L., & Yu, J. (2009) · Oncogene · doi:10.1038/onc.2009.451 · Cited by 140
S and G2 Phase Roles for Cdk2 Revealed by Inducible Expression of a Dominant-Negative Mutant in Human Cells
Hu, B., Mitra, J., van den Heuvel, S., & Enders, G. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2755-2766.2001 · Cited by 137
CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
Chen, M., Liang, J., Ji, H., Yang, Z., Altilia, S., Hu, B., Schronce, A., McDermott, M. S. J., Schools, G. P., Lim, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710467114 · Cited by 143
MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells
Liu, Y., Borchert, G. L., Donald, S. P., Surażyński, A., Hu, C. A., Weydert, C. J. D., Oberley, L. W., & Phang, J. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi083 · Cited by 136
Non-Canonical Cell Death Induced by p53
Ranjan, A., & Iwakuma, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122068 · Cited by 140
The tumour suppressor RASSF1A promotes MDM2 self‐ubiquitination by disrupting the MDM2–DAXX–HAUSP complex
Song, M. S., Song, S. J., Kim, S. Y., Oh, H. J., & Lim, D. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.115 · Cited by 137
Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
Frank, M. B., Yang, Q., Osban, J., Azzarello, J. T., Saban, M. R., Saban, R., Ashley, R. A., Welter, J. C., Fung, K.-M. A., & Lin, H. (2009) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-9-6 · Cited by 134
RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcriptPreprint
Shu, L., Yan, W., & Chen, X. (2006) · Genes & Development · doi:10.1101/gad.1463306 · Cited by 134
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21
Wang, Y., Fisher, J. C., Mathew, R., Li, O., Otieno, S. B., Sublet, J., Xiao, L., Chen, J., Roussel, M. F., & Kriwacki, R. W. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.536 · Cited by 133
p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage
Aoubala, M., Murray-Zmijewski, F., Khoury, M. P., Fernandes, K., Perrier, S., Bernard, H., Prats, A., Lane, D. P., & Bourdon, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.91 · Cited by 138
RETRACTED: Elevated tRNAiMet Synthesis Can Drive Cell Proliferation and Oncogenic Transformation
Marshall, L., Kenneth, N. S., & White, R. J. (2008) · Cell · doi:10.1016/j.cell.2008.02.035 · Cited by 134
Retracted
Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems
Anwar, A., Dehn, D. L., Siegel, D. M., Kepa, J. K., Tang, L. J., Pietenpol, J. A., & Ross, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211981200 · Cited by 132
Hereditary breast cancer
Robson, M. E., Boyd, J. A., Borgen, P. I., & Cody, H. S. (2001) · Current Problems in Surgery · doi:10.1016/s0011-3840(01)70035-4 · Cited by 133
DNA damage induces downregulation of histone gene expression through the G1 checkpoint pathway
Su, C., Gao, G., Schneider, S. M., Helt, C. E., Weiß, C., O’Reilly, M. A., Bohmann, D., & Zhao, J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600120 · Cited by 135
Notch-1 regulates transcription of the epidermal growth factor receptor through p53
Purow, B. W., Sundaresan, T. K., Burdick, M. J., Kefas, B. A., Comeau, L., Hawkinson, M. P., Su, Q., Kotliarov, Y., Lee, J., Zhang, W., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn079 · Cited by 132
Cdc7-Dbf4 Kinase Overexpression in Multiple Cancers and Tumor Cell Lines Is Correlated with p53 Inactivation
Bonte, D., Lindvall, C. J., Liu, H., Dykema, K. J., Furge, K., & Weinreich, M. (2008) · Neoplasia · doi:10.1593/neo.08216 · Cited by 131
Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
Lee, W., Belkhiri, A., Lockhart, A. C., Merchant, N. B., Glaeser, H., Harris, E. I., Washington, M. K., Brunt, E. M., Zaika, A., Kim, R. B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1984 · Cited by 130
Identification of sites of 2′-O-methylation vulnerability in human ribosomal RNAs by systematic mapping
Sharma, S., Marchand, V., Motorin, Y., & Lafontaine, D. L. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09734-9 · Cited by 141
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line
Serafim, T. L., Oliveira, P. J., Sardão, V. A., Perkins, E., Parke, D., & Holy, J. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0558-9 · Cited by 130
Vanadate-Induced Cell Growth Regulation and the Role of Reactive Oxygen Species
Zhang, Z., Huang, C., Li, J., Leonard, S. S., Lanciotti, R. S., Butterworth, L. F., & Shi, X. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2464 · Cited by 130
Low-Dose Radiation Hypersensitivity Is Associated With p53-Dependent Apoptosis
Enns, L., Bogen, K. T., Wizniak, J., Murtha, A. D., & Weinfeld, M. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.557.2.10 · Cited by 130
In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202
Raynaud, F. I., Whittaker, S. R., Fischer, P. M., McClue, S. J., Walton, M. I., Barrie, S. E., Garrett, M. D., Rogers, P., Clarke, S. J., Kèlland, L. R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2264 · Cited by 130
Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
Dash, B. C., & El‐Deiry, W. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3364-3387.2005 · Cited by 129

Authors: Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
Affiliations: Howard Hughes Medical Institute (US)
F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
Corresponding author: Vogelstein, B.
ORCID: Bunz, F.
Dutriaux, A.
Waldman, T.
Zhou, S.
Brown, J. P.
Sedivy, J. M.
Kinzler, K. W.
Vogelstein, B.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1998-11-20
Volume: 282
Issue: 5393
Pages: 1497-1501
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.282.5393.1497
OpenAlex: W2080125477
Cited by: 2,803
References: 50
Citations by year: 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
FWCI: 41.60
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords: p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
MeSH terms: Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks